Evolent Health Inc [EVH] stock prices are up 14.44% to $34.07 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EVH shares have gain 9.02% over the last week, with a monthly amount glided 9.83%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 22, February 2024, Evolent Announces Fourth Quarter and Full Year 2023 Results. In a post published today on Yahoo Finance, Full year revenue of $1,963.9 million, 45% growth over 2022.
From an analyst’s perspective:
Evolent Health Inc [NYSE: EVH] stock has seen the most recent analyst activity on January 03, 2024, when Barclays initiated its Overweight rating and assigned the stock a price target of $39. Previously, JMP Securities started tracking the stock with Mkt Outperform rating on December 06, 2023, and set its price target to $37. On October 16, 2023, UBS initiated with a Buy rating and assigned a price target of $46 on the stock. Stephens started tracking the stock assigning a Overweight rating and suggested a price target of $40 on April 12, 2023. Truist initiated its recommendation with a Hold and recommended $33 as its price target on November 01, 2022. RBC Capital Mkts started tracking with a Outperform rating for this stock on July 29, 2022, and assigned it a price target of $40. In a note dated March 30, 2022, Guggenheim initiated an Buy rating and provided a target price of $43 on this stock.
The stock price of Evolent Health Inc [EVH] has been fluctuating between $23.33 and $36.70 over the past year. Currently, Wall Street analysts expect the stock to reach $47.5 within the next 12 months. Evolent Health Inc [NYSE: EVH] shares were valued at $34.07 at the most recent close of the market. An investor can expect a potential return of 39.42% based on the average EVH price forecast.
Analyzing the EVH fundamentals
The Evolent Health Inc [NYSE:EVH] reported sales of 1.96B for trailing twelve months, representing a surge of 45.40%. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 32.22 points at the first support level, and at 30.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.99, and for the 2nd resistance point, it is at 35.92.
Evolent Health Inc [EVH] reported earnings per share of $0.3 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.07/share, meaning a difference of $0.23 and a surprise factor of 328.60%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were $0.14 per share as compared to estimates of $0.11 per share, a difference of $0.03 representing a surprise of 27.30%.
Ratios To Look Out For
It’s worth pointing out that Evolent Health Inc [NYSE:EVH]’s Current Ratio is 1.01. Further, the Quick Ratio stands at 1.01, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 1.99, the price to book ratio is 3.63.
Transactions by insiders
Recent insider trading involved Blackley Seth, Chief Executive Officer, that happened on Dec 05 when 0.14 million shares were sold. PRESIDENT, McCarthy Daniel Joseph completed a deal on Nov 15 to sell 11000.0 shares. Meanwhile, Chief Operating Officer Rafferty Emily Ann sold 7900.0 shares on Aug 15.
